全文获取类型
收费全文 | 3433篇 |
免费 | 99篇 |
国内免费 | 19篇 |
专业分类
耳鼻咽喉 | 9篇 |
儿科学 | 63篇 |
妇产科学 | 49篇 |
基础医学 | 527篇 |
口腔科学 | 32篇 |
临床医学 | 324篇 |
内科学 | 868篇 |
皮肤病学 | 103篇 |
神经病学 | 299篇 |
特种医学 | 126篇 |
外科学 | 332篇 |
综合类 | 15篇 |
预防医学 | 239篇 |
眼科学 | 40篇 |
药学 | 295篇 |
中国医学 | 10篇 |
肿瘤学 | 220篇 |
出版年
2023年 | 10篇 |
2022年 | 11篇 |
2021年 | 32篇 |
2020年 | 19篇 |
2019年 | 26篇 |
2018年 | 27篇 |
2017年 | 18篇 |
2016年 | 18篇 |
2015年 | 38篇 |
2014年 | 56篇 |
2013年 | 94篇 |
2012年 | 208篇 |
2011年 | 222篇 |
2010年 | 98篇 |
2009年 | 136篇 |
2008年 | 247篇 |
2007年 | 271篇 |
2006年 | 250篇 |
2005年 | 317篇 |
2004年 | 257篇 |
2003年 | 240篇 |
2002年 | 272篇 |
2001年 | 42篇 |
2000年 | 29篇 |
1999年 | 46篇 |
1998年 | 60篇 |
1997年 | 50篇 |
1996年 | 43篇 |
1995年 | 35篇 |
1994年 | 36篇 |
1993年 | 44篇 |
1992年 | 20篇 |
1991年 | 16篇 |
1990年 | 20篇 |
1989年 | 18篇 |
1988年 | 14篇 |
1987年 | 9篇 |
1986年 | 15篇 |
1985年 | 15篇 |
1984年 | 20篇 |
1983年 | 16篇 |
1982年 | 19篇 |
1981年 | 22篇 |
1980年 | 18篇 |
1979年 | 14篇 |
1978年 | 6篇 |
1977年 | 7篇 |
1976年 | 12篇 |
1975年 | 12篇 |
1974年 | 6篇 |
排序方式: 共有3551条查询结果,搜索用时 984 毫秒
91.
Pascale Mustapha Isabelle Paris Magali Garcia Cong Tri Tran Julie Cremniter Martine Garnier Jean-Pierre Faure Thierry Barthes Ivo G. Boneca Franck Morel Jean-Claude Lecron Christophe Burucoa Charles Bodet 《Infection and immunity》2014,82(7):2881-2889
Helicobacter pylori infection systematically causes chronic gastric inflammation that can persist asymptomatically or evolve toward more severe gastroduodenal pathologies, such as ulcer, mucosa-associated lymphoid tissue (MALT) lymphoma, and gastric cancer. The cag pathogenicity island (cag PAI) of H. pylori allows translocation of the virulence protein CagA and fragments of peptidoglycan into host cells, thereby inducing production of chemokines, cytokines, and antimicrobial peptides. In order to characterize the inflammatory response to H. pylori, a new experimental protocol for isolating and culturing primary human gastric epithelial cells was established using pieces of stomach from patients who had undergone sleeve gastrectomy. Isolated cells expressed markers indicating that they were mucin-secreting epithelial cells. Challenge of primary epithelial cells with H. pylori B128 underscored early dose-dependent induction of expression of mRNAs of the inflammatory mediators CXCL1 to -3, CXCL5, CXCL8, CCL20, BD2, and tumor necrosis factor alpha (TNF-α). In AGS cells, significant expression of only CXCL5 and CXCL8 was observed following infection, suggesting that these cells were less reactive than primary epithelial cells. Infection of both cellular models with H. pylori B128ΔcagM, a cag PAI mutant, resulted in weak inflammatory-mediator mRNA induction. At 24 h after infection of primary epithelial cells with H. pylori, inflammatory-mediator production was largely due to cag PAI substrate-independent virulence factors. Thus, H. pylori
cag PAI substrate appears to be involved in eliciting an epithelial response during the early phases of infection. Afterwards, other virulence factors of the bacterium take over in development of the inflammatory response. Using a relevant cellular model, this study provides new information on the modulation of inflammation during H. pylori infection. 相似文献
92.
93.
94.
95.
96.
97.
Gayda M Bourassa MG Tardif JC Fortier A Juneau M Nigam A 《The Canadian journal of cardiology》2012,28(2):201-207
Background
The long-term prognostic value of heart rate recovery (HRR) has been incompletely documented in patients with coronary artery disease (CAD). We sought to confirm the prognostic value of HRR in a large cohort with stable CAD.Methods
From the Coronary Artery Surgery Study registry, a database of 24,958 patients with CAD who underwent cardiac catheterization between 1974 and 1979, we identified 4097 patients with baseline exercise stress testing data. HRR was measured at 3 minutes post exercise during a passive recovery. Clinical outcomes were evaluated according to HRR in both threshold and continuous models.Results
Median long-term follow-up was 14.7 years (interquartile range, 9.8-16.2). HRR < 46 beats per minute (Bpm) most appropriately differentiated nonsurvivors from survivors (area under receiver operating characteristic curve = 0.613) and was associated with an increased risk of all-cause death (adjusted hazard ratio = 1.15; P = 0.011). Increasing HRR was associated with a lower risk of all-cause (adjusted hazard ratio = 0.94 per 10 Bpm; 95% confidence interval, 0.91-0.97; P = 0.0005) and cardiovascular (CV) mortality (adjusted hazard ratio = 0.94 per 10 Bpm; 95% confidence interval, 0.90-0.98; P = 0.003).Conclusions
HRR at 3 minutes independently predicts long-term all-cause and CV mortality in patients with stable CAD. Measurement of HRR at 3 minutes during passive recovery can be used as a complementary tool to identify patients with a higher total and CV risk. 相似文献98.
Mabo P Defaye P Mouton E Cebron JP Davy JM Tassin A Babuty D Mondoly P Paziaud O Anselme F Daubert JC 《Journal of cardiovascular electrophysiology》2012,23(8):853-860
Impact of Recalls on ICD Utilization . Introduction: The study was designed to evaluate the feasibility and performance of right ventricular (RV) mid‐septal versus apical implantable defibrillator (ICD) lead placement. Methods and Results: SEPTAL is a randomized, noninferiority trial, which randomly assigned patients to implantation of ICD leads in the RV mid‐septum versus apex, with a primary objective of comparing the implant success rate of implant at each site, based on strict electrical predefined criteria. We also compared the (1) pacing lead characteristics, (2) rates of appropriate and inappropriate ICD therapies, and (3) all‐cause mortality between the 2 sites at 1 year. The trial enrolled 215 patients (mean age = 59.7 ± 12.4 years, mean LVEF = 34.0 ± 14.2%, 84.2% men), of whom 148 (68.8%) presented with ischemic heart disease. The ICD indication was primary prevention in 117 patients (54.4%). The lead was successfully implanted in 96/107 patients (89.7%) assigned to the RV mid‐septum, and in 99/108 (91.7%) assigned to the apex (ns). The 1‐year rate of lead‐related adverse events was similar in both groups. A total of 8 first inappropriate ICD therapies (7.9%) were delivered in the RV mid‐septal group, versus 8 (7.8%) in the apical group (ns), while first appropriate therapies were delivered to 22 (21.4%) and 24 patients (23.8%), respectively (ns). All‐cause mortality was 7.9% in the RV mid‐septal versus 2.9% in the RV apical group (ns). Conclusion: This study confirmed the technical feasibility and noninferior performance of ICD leads implanted in the RV mid‐septum versus the apex. (J Cardiovasc Electrophysiol, Vol. 23, pp. 853‐860, August 2012) 相似文献
99.
100.
Atherosclerotic cardiovascular disease (CVD) is a complex disorder that leads to premature death and hospitalization. Several drugs have been, or are currently being tested for their ability to reduce cardiovascular mortality and/or promote regression of atherosclerotic lesions. In addition to "hard end point" clinical trials in which total and cardiovascular mortality as well as risk of incident myocardial infarction are considered as outcomes, trials with surrogate end points using imaging biomarkers can rapidly assess the efficacy of new cardiovascular drugs. Low-density lipoprotein-based therapies with statins have been shown to promote atherosclerosis regression, and several other drugs targeting high-density lipoproteins or inflammation/oxidation are currently being tested in both outcomes and imaging trials in which atherosclerosis regression is anticipated. In this review, we focus on the latest progress in CVD and highlight novel drugs that tackle atherosclerosis as well as the currently used and upcoming imaging techniques to optimally measure atherosclerosis progression. 相似文献